CWU-88468-28693
2 vaccinations
1 coded response
1 check-in
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 665 / KS
- Registered
- 2023-02-15
- Relationship
- Child or adolescent in my care
- Guardian
- 9H3-23677-28592
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-02-15
Dose 1 — Pfizer-BioNTech
-
2022-03-15
Dose 2 — Pfizer-BioNTech
-
2023-02-15
Registered in v-safe
-
2023-03-17
Survey response — 12 months, dose 2, dependentMedDRA: Premature menarche — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-02-15 | Pfizer-BioNTech | No |
| 2 | 2022-03-15 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Premature menarche | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release